Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin AmyloidosisDavid Adams, Ole B. Suhr, Shahram Attarian et al.|New England Journal of Medicine|2018Cited by 2.9k
Inotersen Treatment for Patients with Hereditary Transthyretin AmyloidosisMerrill D. Benson, Teresa Coelho, Márcia Waddington‐Cruz et al.|New England Journal of Medicine|2018Cited by 1.4k
A degradation-sensitive anionic trypsinogen (PRSS2) variant protects against chronic pancreatitisHeiko Witt, Thomas Berg, Miklós Sahin‐Tóth et al.|Nature Genetics|2006Cited by 250
Identification of mutational hot spots in LMNA encoding lamin A/C in patients with familial dilated cardiomyopathyAndreas Perrot, Cemil Özcelik, Shwan Hussein et al.|Basic Research in Cardiology|2008Cited by 77
Superior Tumor Detection for<sup>68</sup>Ga-FAPI-46 Versus<sup>18</sup>F-FDG PET/CT and Conventional CT in Patients with CholangiocarcinomaKim M. Pabst, Wolfgang P. Fendler, Marija Trajkovic‐Arsic et al.|Journal of Nuclear Medicine|2023Cited by 63